General Information of Drug (ID: DM91UKB)

Drug Name
Tyropanoic acid Drug Info
Synonyms
Acidum tyropanoicum; Bilopac; Bilopaque; LS-187166; SCHEMBL2788021; Sodium Tyropanoate (USAN); TYROPANIC ACID; Tyropanoate sodium(USAN; Tyropanoic acid; Tyropanoic acid sodium salt; Tyropaque; WIN 8851-2; tyropanoate; 2-(3-(Butyrylamino)-2,4,6-triiodobenzyl)butanoic acid; 2-(3-(Butyrylamino)-2,4,6-triiodobenzyl)butyric acid; 2-[3-(butyrylamino)-2,4,6-triiodobenzyl]butanoic acid; 27293-82-9; AC1L1KQH; AC1Q4PCM; API0012761; CHEBI:135862; CHEMBL1201261; CTK4F9414; DB09340; DTXSID5048269; EINECS 248-389-8; NSC107434
Cross-matching ID
PubChem CID
5611
ChEBI ID
CHEBI:135862
CAS Number
CAS 27293-82-9
TTD Drug ID
DM91UKB
INTEDE Drug ID
DR1654

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Drug(s) Metabolized By Beta-glucuronidase (GUSB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Chondroitin sulfate DM0N19Y N. A. N. A. Phase 4 [2]
MK-4827 DMLYGH4 Ovarian cancer 2C73 Phase 3 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Beta-glucuronidase (GUSB) Main DME DEP54UE BGLR_HUMAN Substrate [1]

References

1 Foreign Compound Metabolism in Mammals. Edited by D. E. Hathway.
2 MFN human ref: Chondroitin sulfate degradation.
3 Summary of FDA-approved anticancer cytotoxic drugs at May 2019.